Back in September, Orioles first baseman Chris Davis was suspended for 25 games for testing positive for Adderall, a banned stimulant. He missed 17 games in the regular season and seven postseason games. After he sits out on Opening Day he’ll be eligible once again.
It didn’t have to be that way. Davis had previously obtained a therapeutic use exemption allowing him to take Adderall but, for whatever reason, did not have such an exemption last year. Why he didn’t he has not said, but he didn’t. But that will change in 2015, as Orioles manager Buck Showalter said on Tuesday that Davis has once again received a therapeutic use exemption for next season.
One would assume that his lack of having one last year was not because he was denied — MLB approved over 100 of them last year — but because he did not seek one, as even a lax oversight process for such things would probably not go back and forth with approvals and denials like that. Of course, there are many who question how much one has to show to get such an exemption in the first place given how many players do get it. It’s an . . . interesting little part of baseball’s drug story.
But whatever one thinks of all of that, we know one thing: Davis will be back on Aderall next year.